首页 | 本学科首页   官方微博 | 高级检索  
检索        

阿霉素肾病大鼠模型的优化
引用本文:李爱平,张王宁,秦雪梅.阿霉素肾病大鼠模型的优化[J].中草药,2018,49(1):151-159.
作者姓名:李爱平  张王宁  秦雪梅
作者单位:山西大学中医药现代研究中心, 地产中药功效物质研究与利用山西省重点实验室, 山西 太原 030006,山西大学中医药现代研究中心, 地产中药功效物质研究与利用山西省重点实验室, 山西 太原 030006,山西大学中医药现代研究中心, 地产中药功效物质研究与利用山西省重点实验室, 山西 太原 030006
基金项目:国家自然科学基金资助项目(31570346);国家中药标准化项目:黄芪药材及饮片规格等级和质量标准研究(ZYBZH-Y-JIN-34)
摘    要:目的确定适合于防己黄芪汤药效评价的阿霉素肾病大鼠模型最佳造模方法。方法通过改变阿霉素给药剂量和给药次数,并给予防己黄芪汤系列受试药物进行干预,以大鼠体质量、脏器指数、尿蛋白定量、肾组织病理以及血清生化指标等为评价指标,探索不同的阿霉素给药剂量和次数对模型的影响。结果 M1(5+2)mg/kg]模型,大鼠死亡率较高;M2(6 mg/kg)模型,死亡率高达20%,给予供试药物干预,反映肾功能的各项指标不仅没有回调,反而沿模型组变化方向表现更高的水平;对于M3(4+2)mg/kg]模型,大鼠部分指标:肺脏和肾脏脏器指数、血清三酰甘油(TG)及总蛋白(TP)水平发生回调,但治愈效果并不理想;对于M4或M4’(4+1)mg/kg]模型,于造模第14天,大鼠尿蛋白定量水平与对照组相比,具有显著性差异,且呈现持续稳定增长趋势,给予防己黄芪汤高、中、低剂量,各指标均有不同程度回调。结论最终确定采用大鼠起始造模体质量约300 g,阿霉素造模累计剂量为5 mg/kg,分2次尾iv给药,首次于实验第1天注射4mg/kg,时隔1周,于实验第8天注射1 mg/kg,为最佳造模方式,适合评价由防己黄芪汤衍生的相关受试药物的药效作用。

关 键 词:阿霉素  肾病模型  防己黄芪汤  药效评价  尿蛋白定量
收稿时间:2017/7/19 0:00:00

Optimization of adriamycin-induced nephropathy rat model
LI Ai-ping,ZHANG Wang-ning and QIN Xue-mei.Optimization of adriamycin-induced nephropathy rat model[J].Chinese Traditional and Herbal Drugs,2018,49(1):151-159.
Authors:LI Ai-ping  ZHANG Wang-ning and QIN Xue-mei
Institution:Key Laboratory of Effective Substances Research and Utilization in TCM of Shanxi Province, Modern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan 030006, China,Key Laboratory of Effective Substances Research and Utilization in TCM of Shanxi Province, Modern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan 030006, China and Key Laboratory of Effective Substances Research and Utilization in TCM of Shanxi Province, Modern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan 030006, China
Abstract:Objective To determine the optimal model for the evaluation of pharmacodynamics of Fangji Huangqi Decoction. Methods By changing the doses and times of doxorubicin and the intervention of Fangji Huangqi Decoction and a series of test drugs, the effects of different doses and times of doxorubicin on the model were explored, and body weight, organism index, urine protein quantitation, renal histopathology results, and serum biochemistry can be regarded as evaluation indexes. Results For M1 (5 + 2) mg/kg model, the mortality rate of rats was higher. For M2 (6 mg/kg) model, the mortality rate was up to 20%, and the indicators reflecting renal function did not callback, but instead it showed much higher levels than the model group after receiving the test drug. For M3 (4 + 2) mg/kg model, the callback of part of the indexes, such as lung and kidney organ index, serum total triglyceride, and total protein levels, occurred after receiving the test drug, but the curative effect is not ideal. For M4 or M4'' (4 + 1) mg/kg model, the quantitative level of urinary protein in model rats was significantly different from that in the control at the 14th d, and the sustained and stable growth trend was observed; Moreover, the indicators mentioned above have different degrees of callback with high-, middle-, and low dose of Fangji Huangqi Decoction. Conclusion The final model weight of the rats was determined to be about 300 g, and the cumulative dose of doxorubicin was 5 mg/kg tail intravenous injection of doxorubicin was adopted as follows:on the 1st d of the experiment, 4 mg/kg doxorubicin was injected, and followed another 1 mg/kg at intervals of 1 week, which was the best way to evaluate the pharmacological effect of the related drugs derived from the Fangji Huangqi Decoction and the middle dose was the best.
Keywords:doxorubicin  nephropathy model  pharmaceutical evaluation  Fangji Huangqi Decoction  urinary protein quantitative
本文献已被 CNKI 等数据库收录!
点击此处可从《中草药》浏览原始摘要信息
点击此处可从《中草药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号